Seneca Growth Capital Vct Share Price (HYG)

Share Name Share Symbol Market Type Share ISIN Share Description
Seneca Growth Capital Vct Plc LSE:HYG London Ordinary Share GB0031256109 ORD 1P
  Price Change % Change Share Price Shares Traded Last Trade
  0.00 0.0% 22.00 0.00 01:00:00
Bid Price Offer Price High Price Low Price Open Price
20.00 24.00 22.00 22.00 22.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 0.00 2
Last Trade Time Trade Type Trade Size Trade Price Currency
- O 0 22.00 GBX
Related Shares
Scottish Mortgage Invest... (SMT), M&g (MNG), Energiser Investments (ENGI), Tiger Resource (TIR)

Seneca Growth Capital Vct (HYG) Latest News

Seneca Growth Capital Vct News

Date Time Source Headline
28/10/201907:00UKREGSeneca Growth Capital VCT plc Second Interim Dividend
08/10/201913:55UKREGHygea VCT plc Issue Of Equity
08/10/201907:00UKREGHygea VCT plc Update For The Quarter Ended 30 September 2019
17/7/201908:00UKREGHygea VCT plc Correction: Offer For Subscription
16/7/201917:27UKREGHygea VCT plc Offer For Subscription
10/7/201917:20UKREGHygea VCT plc Half-year Report
More Seneca Growth Capital Vct News
Seneca Growth Capital Vct Takeover Rumours

Seneca Growth Capital Vct (HYG) Discussions and Chat

Seneca Growth Capital Vct Forums and Chat

Date Time Title Posts
13/2/202010:11HYGEA VCT : medical technology company VCT204
17/1/200519:21Honeygrove Group - was Propan Homes514
23/10/200321:33PETER O'REILLY UPS STAKE, SOMETHING GOING On4
16/10/200316:41HYG Charts2

Add a New Thread

Seneca Growth Capital Vct (HYG) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Seneca Growth Capital Vct trades in real-time

Seneca Growth Capital Vct (HYG) Top Chat Posts

DateSubject
10/4/2020
09:20		Seneca Growth Capital Vct Daily Update: Seneca Growth Capital Vct Plc is listed in the Equity Investment Instruments sector of the London Stock Exchange with ticker HYG. The last closing price for Seneca Growth Capital Vct was 22p.
Seneca Growth Capital Vct Plc has a 4 week average price of 0p and a 12 week average price of 20p.
The 1 year high share price is 39p while the 1 year low share price is currently 20p.
There are currently 8,115,376 shares in issue and the average daily traded volume is 0 shares. The market capitalisation of Seneca Growth Capital Vct Plc is £1,785,382.72.
Read Full Thread
Reply
09/1/2020
08:43		jonesy100: Thanks for posting Rivaldo. On current SCLP share price, I reckon HYG is still at a 30%+ discount to NAV so once this factors in, that should make it even better
Read Full Thread
Follow
Reply
09/1/2019
12:47		rivaldo: Of course the price will either multi-bag if SCLP does well or will fall if not. But I'm also confident that ODX will do well over time. And there's also a large investment in OR Productivity, plus Arecor seems to be doing pretty well. Plus HYG now have a large cash pile to support the share price and to invest in new ventures or support existing investments.
Read Full Thread
Follow
Reply
01/9/2016
12:40		rivaldo: Interims out - NAV down to 69.1p due to the decline in SCLP's share price. SCLP is up some 10% since 30/6, so I would expect NAV to be up nearer say 71p now: Http://www.investegate.co.uk/hygea-vct-plc--hyg-/gnw/hygea-vct-plc---half-yearly-report/20160831070031H8373/ Hallmarq is still progressing very well. It's surely just a matter of time before it IPO's on AIM, at which point I'd expect NAV serious upside. I'm also hopeful for the £450k carrying value in AIM-quoted ODX - this could be worth a lot more in a few months' time with decent news flow.
Read Full Thread
Follow
Reply
10/6/2014
09:13		timbo003: Tristel worth keeping an eye on. Up around 20% today following a trading update and now up around 65% this year, they accounted for 0.6p/share of Hygea's NAV at year end, so that should be more like 1p/share now. http://uk.advfn.com/exchanges/LSE/tristel-TSTL/share-price?java=1
Read Full Thread
Follow
Reply
01/4/2014
14:17		rivaldo: Results just out: Http://www.investegate.co.uk/hygea-vct-plc--hyg-/gnw/hygea-vct-plc---annual-financial-report-and-agm/20140401134723H3425/ 97p NAV now, so the share price is at a substantial discount. SCLP will either be a massive winner or a total flop I suppose. But Hallmarq looks better and better imo. It made £648k PBT to 31/8/13 at a pretty reasonable £10m valuation - and that's before any contribution from the now-launched Petvet, which has a massive global market. I wish I could buy shares directly in Hallmarq. And Eykona suddenly looks like being a bit of a goer since it's suddenly been discovered at the heart of the 3D printing industry: "Eykona became aware of the opportunity within the 3D printing market to develop its camera as the world's first high resolution 3D scanner for the consumer market." If progress in the USA continues, who knows what it might become worth?
Read Full Thread
Follow
Reply
25/2/2014
08:44		rivaldo: ODX has roughly doubled over the last few weeks. At 30/6/13 HYG's holding was worth £437k, so this must now be worth around £850k or so - quite a significant increase in the context of HYG's £5.4m m/cap. EKF is also rising nicely, to 38p now and a £475k worth to HYG. HYG is developing nicely, with SCLP, Hallmarq, ODX and EKF providing a variety of supports for the share price and NAV.
Read Full Thread
Follow
Reply
20/1/2014
07:24		timbo003: Today's RNS from EKF sounds more than just interesting. http://www.investegate.co.uk/ekf-diagnostics-hldg--ekf-/rns/pointman-enriches-low-level-mutations-from-blood/201401200700170025Y/ At the last full valuation (June 30th), EKF accounted for 4p/share of Hygea's NAV (with the underlying share price for EKF at around 26p/share), at close on Friday, EKF were around 35p/share, so presumably they currently account for around 5.5p/share of Hygea's NAV. I suspect EKF will have an "up" day today. Here's the link to their summary quote page: http://uk.advfn.com/p.php?pid=quote&symbol=L%5eEKF
Read Full Thread
Follow
Reply
03/10/2013
19:11		timbo003: It was at the Scancell Investor day on Tuesday, there are a number of write ups of the event on the LSE Scancell BB, my own version of events is on the ADVFN Scancell thread After the meeting I had a chance to chat to a few people, including: a couple of ADVFNers, Lucius (chief cheese fund manager for the Oxford VCTs), James (Chairman and fund manager at Hygea VCT) and Chris (market maker at Panmure). The Oxford VCTs took up their allocation in the open offer, Hygea did not (for technical reasons), both Lucius and James seemed impressed with the Scancell BOD and with progress. I do not think they will be selling. Note also that the Hygea share price (which usually tracks the Scancell share price) did not follow Scancell down yesterday, which I suspect was after all the praise that James was showering on Hallmarq (in reponse to a question from me). He was incredibly bullish on Hallmarq, but he says the problem is assigning a value, none of the current PE valuations are really appropriate.
Read Full Thread
Follow
Reply
20/5/2013
22:42		rivaldo: Timbo, I hope you don't mind me copying here your poat from T.M.F re HYG as it's a useful prompter - though I think Freehand is actually now the second biggest investment, with EKF perhaps third (as an aside, personally I can't see much upside for EKF at the current high valuation for some time to come) : http://boards.fool.co.uk/there-is-a-useful-agm-report-for-ekf-diagnostics-12810965.aspx "There is a useful AGM report for EKF Diagnostics over on the Sharesoc forum (you need to register to read, but its free): http://sharesoc.ning.com/forum/topics/the-agm-forum?commentI... EKF are the second largest Aim quoted investmment in the Hygea portfolio, summary details are here http://www.investegate.co.uk/CompData.aspx?EKF EKF was on Hygea's books at £354K at 31st December and the share price is now more or less where it was at the end of the year (30p), so it contributes around 3.5p/share of Hygea's NAV (adjusted for management incentive). Interesting to read that there were two approaches for EKF last year, one of which was "serious" from a large international player and the possible reasons why it did not proceed. Perhaps it's only a matter of time before EKF get taken out. Should this occur, it would represent a significant liquidy event and profit for Hygea (they bought their stake for £260K)."
Read Full Thread
Follow
Reply
07/10/2012
07:01		timbo003: rivaldo By my calculations, if SCLP share price is 49p, then NAV for Hygea (using Hygea's own methodology of taking the performance incentive into account) would be 120p (not 128p). The reasoning goes like this: Without correcting for the performance incentive, every 1p increase in SCLP increases Hygea NAV by 1.82p With correction for the performance incentive (which kicks now NAV total return >80p), every 1p increase in SCLP increases Hygea NAV by 1.51p (i.e 1.82 *5/6) Taking Hygea's own figures at the last update: i.e. SPLC at 32p gives a Hygea NAV of 94p, then it follows that by applying a 1.51X muliplier, that a SPLC share price of 49p, corresponds to a Hygea NAV of 120p (approx). Could someone else carefully check over the maths and performance incentive detail please, as this is an important point now SPLC is charging ahead, I'll be delighted to be corrected if I've made an error.
Read Full Thread
Follow
Reply
Seneca Growth Capital Vct share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
LSE
HYG
Seneca Gro..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200410 20:25:08